Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis

• Main Authors: Hanan Mohamed El Kahky (Author), Heba Mahmoud Diab (Author), Dalia Gamal Aly (Author), Nehal Magdi Farag (Author)
• 格式: 图书
• 出版: Hindawi Limited, 2013-01-01T00:00:00Z.
• 主题: article
• 在线阅读: Connect to this object online.

Background. Two preparations of botulinum A toxin (BTX-A) are commercially available for the treatment of palmar hyperhidrosis (PPH): Botox (Allergan; 100 U/vial) and Dysport (Ipsen Limited; 500 U/vial), which are not bioequivalent. Results regarding an appropriate conversion factor between them are...